197,206 Shares in Smith & Nephew plc (NYSE:SNN) Bought by ABC Arbitrage SA

ABC Arbitrage SA bought a new position in Smith & Nephew plc (NYSE:SNN) during the fourth quarter, according to its most recent filing with the SEC. The firm bought 197,206 shares of the medical equipment provider’s stock, valued at approximately $4,847,000.

A number of other hedge funds have also added to or reduced their stakes in the stock. Creative Planning raised its position in shares of Smith & Nephew by 28.6% in the third quarter. Creative Planning now owns 62,319 shares of the medical equipment provider’s stock valued at $1,941,000 after purchasing an additional 13,845 shares during the period. Blue Trust Inc. boosted its holdings in Smith & Nephew by 460.5% in the 3rd quarter. Blue Trust Inc. now owns 4,658 shares of the medical equipment provider’s stock valued at $145,000 after purchasing an additional 3,827 shares during the period. Raymond James & Associates increased its holdings in shares of Smith & Nephew by 172.1% in the third quarter. Raymond James & Associates now owns 128,854 shares of the medical equipment provider’s stock worth $4,013,000 after purchasing an additional 81,500 shares during the period. Allspring Global Investments Holdings LLC boosted its stake in Smith & Nephew by 74.4% during the third quarter. Allspring Global Investments Holdings LLC now owns 3,025 shares of the medical equipment provider’s stock valued at $94,000 after buying an additional 1,290 shares during the period. Finally, Signaturefd LLC boosted its position in shares of Smith & Nephew by 18.7% during the 3rd quarter. Signaturefd LLC now owns 15,119 shares of the medical equipment provider’s stock valued at $471,000 after acquiring an additional 2,384 shares during the last quarter. Institutional investors and hedge funds own 25.64% of the company’s stock.

Analysts Set New Price Targets

Several analysts have issued reports on SNN shares. Berenberg Bank lowered Smith & Nephew from a “buy” rating to a “hold” rating in a research note on Wednesday, November 6th. Deutsche Bank Aktiengesellschaft downgraded shares of Smith & Nephew from a “buy” rating to a “hold” rating in a research note on Friday, November 1st. Finally, StockNews.com lowered shares of Smith & Nephew from a “strong-buy” rating to a “buy” rating in a report on Tuesday, November 12th.

Smith & Nephew Trading Up 0.0 %

Shares of SNN stock opened at $25.72 on Friday. The firm’s 50 day moving average is $25.02 and its 200 day moving average is $27.45. The company has a debt-to-equity ratio of 0.63, a quick ratio of 1.11 and a current ratio of 2.51. Smith & Nephew plc has a 12-month low of $23.65 and a 12-month high of $31.72.

About Smith & Nephew

Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. It operates through the following segments: Orthopaedics, Sports Medicine and ENT, and Advanced Wound Management. The Orthopaedics and Sports Medicine and ENT segment consists of the following businesses: knee implants, hip implants, other reconstruction, trauma, sports medicine joint repair, arthroscopic enabling technologies, and ENT.